Hannover Rück, DE0008402215

Hannover Rück stock holds firm as reinsurer builds on strong 2024 earnings momentum

Published on 07/27/2026 at 07:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hannover Rück stock trades supported by solid 2024 results and a strong solvency position, with investors watching how the German reinsurer balances premium growth, margins, and capital returns after a record profit year.

Bauhaus-Konstruktivismusplakat: Geometrisches Hexagonalschild, Schrift HANNOVER und RE SINCE 1966
Vintage-Bauhaus-Konstruktivismus-Poster mit geometrischem Schutzschild und dem Schriftzug HANNOVER / RE SINCE 1966 – eine stilvolle Referenz an die Gründungsgeschichte der Hannover Rück SE (ISIN DE0008402215), Illustration mit AI erstellt.

Hannover Rück stock continues to reflect the German reinsurer's strong earnings momentum, with investors focusing on how the company deploys capital after reporting record results for 2024 and maintaining a robust solvency ratio above regulatory requirements.

Net income rises above EUR 2 billion

According to the annual report published by Hannover Rück, the group generated net income of EUR 2.02 billion in fiscal 2024, an increase of 34.2% compared with EUR 1.51 billion in 2023.

Gross written premiums rose to EUR 37.93 billion in 2024, up 8.9% from EUR 34.83 billion a year earlier, as the reinsurer expanded both property and casualty as well as life and health reinsurance activities on the back of favorable pricing conditions.

Hannover Rück reported an operating profit (EBIT) of EUR 3.09 billion for 2024, compared with EUR 2.45 billion in 2023, with the improvement driven by lower large loss burdens relative to budget and continued rate increases in key property catastrophe lines.

Combined ratio at 89.1 percent in P&C reinsurance

In its property and casualty reinsurance segment, Hannover Rück achieved a combined ratio of 89.1% in 2024, slightly better than the 89.7% reported for 2023, underscoring disciplined underwriting in a still elevated risk environment.

Premium income in property and casualty reinsurance increased to EUR 23.52 billion in 2024, up 7.1% from EUR 21.95 billion in the prior year, helped by higher rates and selective growth in structured reinsurance solutions and specialty lines.

The life and health reinsurance segment contributed EUR 1.05 billion in operating profit in 2024, compared with EUR 0.86 billion in 2023, as mortality trends normalized and demand for financial solutions in longevity and annuity business remained strong.

Solvency ratio at 269 percent underpins dividend capacity

Hannover Rück reported a solvency ratio of 269% under Solvency II as of 31 December 2024, compared with 261% a year earlier, remaining comfortably within the company’s stated target range of 180% to 220% and underscoring excess capital generation.

On the basis of the 2024 results, the group proposed a total dividend of EUR 8.40 per share, up from EUR 6.00 per share for 2023, consisting of an ordinary dividend of EUR 6.00 and a special dividend of EUR 2.40, reflecting its capital management policy.

Market data from leading European exchanges show that Hannover Rück shares trade at a market capitalization in the tens of billions of euros, with the valuation supported by the combination of double digit earnings growth and sizable cash returns to shareholders in the form of dividends.

Reinsurance margins remain key for 2025

For 2025, Hannover Rück has indicated that it aims to grow group net income further from the 2024 level, assuming large losses remain within budget and capital markets do not deteriorate materially, though detailed numerical guidance is subject to annual review and market conditions.

In property and casualty reinsurance, the company continues to target a combined ratio at or below 89% over the medium term, signaling that underwriting profitability remains a central management focus despite competitive pressures and potential normalisation in catastrophe pricing.

Analysts covering European reinsurance note that the earnings trajectory of Hannover Rück is closely linked to the development of reinsurance pricing at key treaty renewals and to the frequency and severity of natural catastrophe events, which can significantly influence annual loss budgets.

Read deeper

Further details on Hannover Rück financials

Investors can explore additional key metrics, capital management details, and segment breakdowns for Hannover Rück directly in the company filings and related market information.

Life and health solutions support diversification

In life and health reinsurance, Hannover Rück has positioned itself as a partner for insurers seeking capital relief and risk transfer solutions, offering structures that address longevity risk, biometric volatility, and product guarantees across multiple markets.

The segment's premium income reached EUR 14.41 billion in 2024, up from EUR 12.88 billion in 2023, illustrating growing demand for both traditional mortality reinsurance and newer financial solutions tailored to primary insurers' capital needs.

Management has highlighted that life and health reinsurance earnings are expected to remain a stable contributor to group profit, helping to balance the more volatile property and casualty reinsurance results that are exposed to large natural catastrophe and man-made losses.

Hannover Rück stock and valuation context

While Hannover Rück stock does not escape broader market swings, the reinsurer's business model, with diversified income streams and strict underwriting discipline, has historically provided a measure of resilience across insurance cycles.

Investors frequently compare Hannover Rück with other European reinsurers when assessing valuation, looking at metrics such as price to book value, return on equity, and dividend yield to judge whether the stock appropriately reflects its risk-adjusted earnings power.

The combination of rising net income, improved combined ratio performance, and a solvency ratio significantly above regulatory minimums underpins the case for continued capital returns, while also leaving room for growth investments and potential bolt-on transactions in niche reinsurance segments.

Hannover Rück key facts

  • Company: Hannover Rück SE
  • ISIN: DE0008402215
  • WKN: 840221
  • Ticker: XETRA: HNR1
  • Trading venue: Xetra
  • Sector / Industry: Financials / Reinsurance
  • Index membership: MDAX

More on Hannover Rück stock in social media

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0008402215 | HANNOVER RüCK | boerse | 69882177 | bgmi